Bizarre parosteal osteochondromatous proliferation

From WikiMD's WELLNESSPEDIA


Bizarre parosteal osteochondromatous proliferation
Synonyms Nora's lesion
Pronounce N/A
Specialty N/A
Symptoms Pain, swelling, palpable mass
Complications Recurrence after surgical removal
Onset Typically in young adults
Duration Chronic
Types N/A
Causes Unknown
Risks Unknown
Diagnosis X-ray, MRI, Histopathology
Differential diagnosis Osteochondroma, Parosteal osteosarcoma, Myositis ossificans
Prevention N/A
Treatment Surgical excision
Medication N/A
Prognosis Generally good, but recurrence is possible
Frequency Rare
Deaths N/A


Other Names: BPOP; Nora lesion; Nora’s Lesion Bizarre Parosteal Osteochondromatous Proliferation (BPOP), also known as Nora’s lesion, is an uncommon, benign bone tumor that grows on the surface of the bone. In some cases, BPOP does not cause symptoms. However, at other times, it can be painful and lead to bone deformity. It is more commonly located on the hands and feet, but can also affect the long bones or bones of the skull and face. A biopsy of the affected bone is important, as BPOP may resemble malignant bone tumors, especially chondrosarcoma or parosteal osteosarcoma. The cause is still unknown though injuries or bone defects may trigger the condition in some cases. Treatment involves surgery to remove the tumor. There is a 20%-50% chance that the condition may reappear after surgery.

NIH genetic and rare disease info[edit]

Bizarre parosteal osteochondromatous proliferation is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.